Disseminated Intravascular Coagulation in Burn Injury

 

 Buy Article Permissions and Reprints

ABSTRACT

Disseminated intravascular coagulation (DIC) is a complex and multifaceted disorder characterized by the activation of coagulation and fibrinolytic pathways, consumption of coagulation factors, and depletion of coagulation regulatory proteins. The introduction into the circulation of cellular debris characterized by strong thromboplastic activity due to tissue factor exposition or release (in or from burned tissues), which can thereby activate extrinsic pathway of coagulation system and trigger massive thrombin generation when present in sufficient concentration, represents the most plausible biological explanation to support the development of intravascular coagulation in patients with burn injury. Severe burns left untreated might also lead to an immunological and inflammatory response (activation of the complement cascade), which can amplify fibrinolysis and blood clotting. Overall, the real prevalence of DIC in patients with burns is as yet unclear. Postmortem, retrospective, and even longitudinal investigations are in fact biased by several factors, such as the objective difficulty to establish whether DIC might have occurred as a primary complication of burns or rather as a consequence of other superimposed pathologies (e.g., sepsis, multiple organ failure), the different diagnostic criteria for assessing DIC, and the heterogeneity of the patient samples studied. Nevertheless, the current scientific evidence is consistent with the hypothesis that biochemical changes suggestive for DIC (hypercoagulability, hypo- and hyperfibrinolysis) are commonplace in patients with burn trauma, and their severity increases exponentially with the severity of injury. Overt DIC seems to occur especially in critically ill burn patients or in those with severe burns (up to third degree) and large involvement of body surface area, in whom an appropriate therapy might be effective to prevent the otherwise fulminant course. Although early prophylaxis with antithrombin concentrates holds promises, especially in the acute phase of thermal injury, larger clinical trials are needed to confirm the benefit of this therapeutic approach.

REFERENCES

• 1 Supple K G. Physiologic response to burn injury.  Crit Care Nurs Clin North Am. 2004;  16(1) 119-126
  CrossrefPubMedGoogle Scholar
• 2 Sheridan R L. Burns.  Crit Care Med. 2002;  30(11, Suppl) S500-S514
  CrossrefPubMedGoogle Scholar
• 3 American Burn Association .National Burn Repository 2009. Available at: http://www.ameriburn.org/2009NBRAnnualReport.pdf Accessed November 6, 2009
  PubMedGoogle Scholar
• 4 World Health Organization .Burn Fact Sheet. Available at: http://www.ameriburn.org/WHO-ISBIBurnFactsheet.pdf Accessed November 6, 2009
  PubMedGoogle Scholar
• 5 World Fire Statistics Centre .World Fire Statistics—October 2009. Available at: http://www.genevaassociation.org/Affiliated_Organizations/WFSC.aspx Accessed November 6, 2009
  PubMedGoogle Scholar
• 6 US Fire Administration .QuickStats: The Overall Fire Picture—2007. US Fire Administration Web site. Available at: http://www.usfa.fema.gov/statistics/quickstats/ Accessed November 6, 2009
  PubMedGoogle Scholar
• 7 Sevitt S. A review of the complications of burns, their origin and importance for illness and death.  J Trauma. 1979;  19(5) 358-369
  CrossrefPubMedGoogle Scholar
• 8 Wassermann D. Systemic complications of extended burns [in French].  Ann Chir Plast Esthet. 2001;  46(3) 196-209
  CrossrefPubMedGoogle Scholar
• 9 Mertens D M, Jenkins M E, Warden G D. Outpatient burn management.  Nurs Clin North Am. 1997;  32(2) 343-364
  PubMedGoogle Scholar
• 10 Serrano C, Acha B, Gómez-Cía T, Acha J I, Roa L M. A computer assisted diagnosis tool for the classification of burns by depth of injury.  Burns. 2005;  31(3) 275-281
  CrossrefPubMedGoogle Scholar
• 11 Faucher L D, Conlon K M. Practice guidelines for deep venous thrombosis prophylaxis in burns.  J Burn Care Res. 2007;  28(5) 661-663
  CrossrefPubMedGoogle Scholar
• 12 McManus W F, Eurenius K, Pruitt Jr B A. Disseminated intravascular coagulation in burned patients.  J Trauma. 1973;  13(5) 416-422
  CrossrefPubMedGoogle Scholar
• 13 Bréan L, Bormioli M, Angela G C, Ferrari F. Coagulation disorders due to burns. Disseminated intravascular coagulation (DIC) and its possible prevention [in Italian].  Minerva Med. 1975;  66(55) 2729-2742
  PubMedGoogle Scholar
• 14 Zuckerman L, Caprini J A, Lipp V, Vagher J P. Disseminated intravascular multiple systems activation (DIMSA) following thermal injury.  J Trauma. 1978;  18(6) 432-439
  CrossrefPubMedGoogle Scholar
• 15 Yoshioka T, Ikemura K, Sawada Y, Ohashi N, Sugimoto H, Sugimoto T. The causes of abnormal coagulation system in the early phase of burns [in Japanese].  Nippon Geka Gakkai Zasshi. 1983;  84(9) 886-890
  PubMedGoogle Scholar
• 16 Wells S, Sissons M, Hasleton P S. Quantitation of pulmonary megakaryocytes and fibrin thrombi in patients dying from burns.  Histopathology. 1984;  8(3) 517-527
  CrossrefPubMedGoogle Scholar
• 17 Ueyama M, Yamamoto I, Sawada Y. Disseminated intravascular coagulation in the early stage after severe burn: the role of excessive thrombin generation [in Japanese].  Nippon Geka Gakkai Zasshi. 1991;  92(8) 907-912
  PubMedGoogle Scholar
• 18 Kowal-Vern A, Gamelli R L, Walenga J M, Hoppensteadt D, Sharp-Pucci M, Schumacher H R. The effect of burn wound size on hemostasis: a correlation of the hemostatic changes to the clinical state.  J Trauma. 1992;  33(1) 50-56 discussion 56-57
  CrossrefPubMedGoogle Scholar
• 19 García-Avello A, Lorente J A, Cesar-Perez J et al.. Degree of hypercoagulability and hyperfibrinolysis is related to organ failure and prognosis after burn trauma.  Thromb Res. 1998;  89(2) 59-64
  CrossrefPubMedGoogle Scholar
• 20 Barret J P, Gomez P A. Disseminated intravascular coagulation: a rare entity in burn injury.  Burns. 2005;  31(3) 354-357
  CrossrefPubMedGoogle Scholar
• 21 Lavrentieva A, Kontakiotis T, Bitzani M et al.. Early coagulation disorders after severe burn injury: impact on mortality.  Intensive Care Med. 2008;  34(4) 700-706
  CrossrefPubMedGoogle Scholar
• 22 Vazina I R, Presniakova M V, Sidorkina A N. Intravascular morphological manifestations of the syndrome of disseminated intravascular coagulation (DIC) in the acute period of burn disease [in Russian].  Vestn Khir Im I I Grek. 2005;  164(6) 58-61
  PubMedGoogle Scholar
• 23 Guest M M, Bond T P. Release of thromboplastin after thermal injury.  Ann N Y Acad Sci. 1968;  150(3) 528-536
  CrossrefPubMedGoogle Scholar
• 24 Ueyama M, Yamamoto I, Sawada Y. Disseminated intravascular coagulation in the early stage after severe burn: the role of excessive thrombin generation [in Japanese].  Nippon Geka Gakkai Zasshi. 1991;  92(8) 907-912
  PubMedGoogle Scholar
• 25 von Bülow S, Hartmann T, Fuchs P C, Schrimpf C, Pallua N. Endothelial thrombomodulin (CD 141) in a rabbit burn model.  Burns. 2005;  31(4) 459-464
  CrossrefPubMedGoogle Scholar
• 26 Van de Wouwer M, Collen D, Conway E M. Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation.  Arterioscler Thromb Vasc Biol. 2004;  24(8) 1374-1383
  CrossrefPubMedGoogle Scholar
• 27 Aoki K, Aikawa N, Sekine K et al.. Elevation of plasma free PAI-1 levels as an integrated endothelial response to severe burns.  Burns. 2001;  27(6) 569-575
  CrossrefPubMedGoogle Scholar
• 28 Kaloudová Y, Lipový B, Zaloudíková Z et al.. International Society on Thrombosis and Haemostasis: disseminated intravascular coagulation score in burns [Abstract].  Burns. 2009;  35(Suppl 1) S46
  PubMedGoogle Scholar
• 29 Ravindranath T M, Goto M, Demir M et al.. Tissue factor pathway inhibitor and thrombin activatable fibrinolytic inhibitor plasma levels following burn and septic injuries in rats.  Clin Appl Thromb Hemost. 2004;  10(4) 379-385
  CrossrefPubMedGoogle Scholar
• 30 Niemi T, Svartling N, Syrjälä M, Asko-Seljavaara S, Rosenberg P. Haemostatic disturbances in burned patients during early excision and skin grafting.  Blood Coagul Fibrinolysis. 1998;  9(1) 19-28
  CrossrefPubMedGoogle Scholar
• 31 Kowal-Vern A, Sharp-Pucci M M, Walenga J M, Dries D J, Gamelli R L. Trauma and thermal injury: comparison of hemostatic and cytokine changes in the acute phase of injury.  J Trauma. 1998;  44(2) 325-329
  CrossrefPubMedGoogle Scholar
• 32 Nurden A T, Bihour C, Macchi L et al.. Platelet activation in thrombotic disorders.  Nouv Rev Fr Hematol. 1993;  35(1) 67-71
  PubMedGoogle Scholar
• 33 Lupia E, Bosco O, Mariano F et al.. Elevated thrombopoietin in plasma of burned patients without and with sepsis enhances platelet activation.  J Thromb Haemost. 2009;  7(6) 1000-1008
  CrossrefPubMedGoogle Scholar
• 34 Kowal-Vern A, McGill V, Walenga J M, Gamelli R L. Antithrombin(H) concentrate infusions are safe and effective in patients with thermal injuries.  J Burn Care Rehabil. 2000;  21(2) 115-127
  CrossrefPubMedGoogle Scholar
• 35 Lavrentieva A, Kontakiotis T, Bitzani M et al.. The efficacy of antithrombin administration in the acute phase of burn injury.  Thromb Haemost. 2008;  100(2) 286-290
  PubMedGoogle Scholar
• 36 Kowal-Vern A, Walenga J M, McGill V, Gamelli R L. The impact of antithrombin (H) concentrate infusions on pulmonary function in the acute phase of thermal injury.  Burns. 2001;  27(1) 52-60
  CrossrefPubMedGoogle Scholar
• 37 Kowal-Vern A, Latenser B A. Antithrombin (human) concentrate infusion in pediatric patients with >50% TBSA burns.  Burns. 2003;  29(6) 615-618
  CrossrefPubMedGoogle Scholar
• 38 Del Principe D. Antithrombin III in burned children [in Italian].  Minerva Anestesiol. 2003;  69(5) 376-380
  PubMedGoogle Scholar
• 39 Franchini M, Lippi G, Guidi G C. The use of recombinant activated factor VII in platelet-associated bleeding.  Hematology. 2008;  13(1) 41-45
  CrossrefPubMedGoogle Scholar
• 40 Franchini M, Lippi G. Acquired factor VIII inhibitors.  Blood. 2008;  112(2) 250-255
  CrossrefPubMedGoogle Scholar
• 41 Franchini M, Franchi M, Bergamini V, Salvagno G L, Montagnana M, Lippi G. A critical review on the use of recombinant factor VIIa in life-threatening obstetric postpartum hemorrhage.  Semin Thromb Hemost. 2008;  34(1) 104-112
  Article in Thieme ConnectPubMedGoogle Scholar
• 42 Franchini M, Manzato F, Salvagno G L, Lippi G. Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with disseminated intravascular coagulation: a systematic review.  Blood Coagul Fibrinolysis. 2007;  18(7) 589-593
  CrossrefPubMedGoogle Scholar
• 43 Martin J T, Alkhoury F, McIntosh B C, Fidler P, Schulz J. Recombinant factor VIIa: hemostatic adjunct in the coagulopathic burn patient.  Eplasty. 2009;  9 e27
  PubMedGoogle Scholar
• 44 Greenhalgh D G, Gamelli R L, Collins J et al.. Recombinant thrombin: safety and immunogenicity in burn wound excision and grafting.  J Burn Care Res. 2009;  30(3) 371-379
  CrossrefPubMedGoogle Scholar

Prof. Giuseppe LippiM.D. 

U.O. di Diagnostica Ematochimica, Azienda Ospedaliero-Universitaria di Parma

Strada Abbeveratoia 2/a, 43100 - Parma, Italy

Email: glippi@ao.pr.it

Email: ulippi@tin.it